217 related articles for article (PubMed ID: 25451106)
1. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.
Tiriveedhi V; Tucker N; Herndon J; Li L; Sturmoski M; Ellis M; Ma C; Naughton M; Lockhart AC; Gao F; Fleming T; Goedegebuure P; Mohanakumar T; Gillanders WE
Clin Cancer Res; 2014 Dec; 20(23):5964-75. PubMed ID: 25451106
[TBL] [Abstract][Full Text] [Related]
2. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.
Tiriveedhi V; Fleming TP; Goedegebuure PS; Naughton M; Ma C; Lockhart C; Gao F; Gillanders WE; Mohanakumar T
Breast Cancer Res Treat; 2013 Feb; 138(1):109-18. PubMed ID: 22678162
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
[TBL] [Abstract][Full Text] [Related]
4. Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.
Soysal SD; Muenst S; Kan-Mitchell J; Huarte E; Zhang X; Wilkinson-Ryan I; Fleming T; Tiriveedhi V; Mohanakumar T; Li L; Herndon J; Oertli D; Goedegebuure SP; Gillanders WE
Breast Cancer Res Treat; 2014 Oct; 147(3):527-37. PubMed ID: 25212176
[TBL] [Abstract][Full Text] [Related]
5. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.
Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T
Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997
[TBL] [Abstract][Full Text] [Related]
6. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors.
Lerret NM; Rogozinska M; Jaramillo A; Marzo AL
PLoS One; 2012; 7(7):e41240. PubMed ID: 22911764
[TBL] [Abstract][Full Text] [Related]
8. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
[TBL] [Abstract][Full Text] [Related]
9. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
Jaramillo A; Majumder K; Manna PP; Fleming TP; Doherty G; Dipersio JF; Mohanakumar T
Int J Cancer; 2002 Dec; 102(5):499-506. PubMed ID: 12432553
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.
Dols A; Smith JW; Meijer SL; Fox BA; Hu HM; Walker E; Rosenheim S; Moudgil T; Doran T; Wood W; Seligman M; Alvord WG; Schoof D; Urba WJ
Hum Gene Ther; 2003 Jul; 14(11):1117-23. PubMed ID: 12885350
[TBL] [Abstract][Full Text] [Related]
11. Design of Polyepitope DNA Vaccine against Breast Carcinoma Cells and Analysis of Its Expression in Dendritic Cells.
Nazarkina ZhK; Khar'kova MV; Antonets DV; Morozkin ES; Bazhan SI; Karpenko LI; Vlasov VV; Ilyichev AA; Laktionov PP
Bull Exp Biol Med; 2016 Feb; 160(4):486-90. PubMed ID: 26915653
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
13. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
14. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
Karkada M; Weir GM; Quinton T; Sammatur L; MacDonald LD; Grant A; Liwski R; Juskevicius R; Sinnathamby G; Philip R; Mansour M
J Immunother; 2010 Apr; 33(3):250-61. PubMed ID: 20445345
[TBL] [Abstract][Full Text] [Related]
15. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
Hung CF; Calizo R; Tsai YC; He L; Wu TC
Vaccine; 2007 Jan; 25(1):127-35. PubMed ID: 16930783
[TBL] [Abstract][Full Text] [Related]
16. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-Induced Memory CD8
Crosby EJ; Gwin W; Blackwell K; Marcom PK; Chang S; Maecker HT; Broadwater G; Hyslop T; Kim S; Rogatko A; Lubkov V; Snyder JC; Osada T; Hobeika AC; Morse MA; Lyerly HK; Hartman ZC
Clin Cancer Res; 2019 May; 25(9):2725-2736. PubMed ID: 30635338
[TBL] [Abstract][Full Text] [Related]
19. Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer.
Aruga A; Takeshita N; Kotera Y; Okuyama R; Matsushita N; Ohta T; Takeda K; Yamamoto M
Clin Cancer Res; 2013 Apr; 19(8):2224-31. PubMed ID: 23479678
[TBL] [Abstract][Full Text] [Related]
20. Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
Clifton GT; Litton JK; Arrington K; Ponniah S; Ibrahim NK; Gall V; Alatrash G; Peoples GE; Mittendorf EA
Ann Surg Oncol; 2017 Aug; 24(8):2161-2167. PubMed ID: 28315060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
